ArticleFrontiers in cell and developmental biology2025
Correction: Tumor organoids may be more suitable for clinical personalized chemotherapeutic drug screening in lung adenocarcinoma.
Wuyang Yun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.